Jens Overgaard

693 total citations
8 papers, 562 citations indexed

About

Jens Overgaard is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jens Overgaard has authored 8 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Otorhinolaryngology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jens Overgaard's work include Head and Neck Cancer Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Jens Overgaard is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Jens Overgaard collaborates with scholars based in Denmark and United Kingdom. Jens Overgaard's co-authors include Marianne Nordsmark, Jan Alsner, Marie Overgaard, Morten Høyer, Olfred Hansen, Anne Berthelsen, Lars Bastholt, Azza A. Khalil, Sally A. Hill and Dietmar W. Siemann and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and Acta Oncologica.

In The Last Decade

Jens Overgaard

8 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Overgaard Denmark 8 221 181 174 162 149 8 562
M.I. Saunders United Kingdom 12 134 0.6× 86 0.5× 128 0.7× 100 0.6× 194 1.3× 30 489
L.A.M. Pop Netherlands 14 369 1.7× 117 0.6× 255 1.5× 223 1.4× 226 1.5× 20 879
A Berthelsen Denmark 8 91 0.4× 154 0.9× 169 1.0× 164 1.0× 59 0.4× 12 420
M. Hjelm-Hansen Denmark 14 224 1.0× 266 1.5× 277 1.6× 363 2.2× 147 1.0× 18 803
Ann M. Chu United States 16 214 1.0× 212 1.2× 114 0.7× 126 0.8× 75 0.5× 30 588
Jimmy Pramana Netherlands 5 171 0.8× 178 1.0× 145 0.8× 107 0.7× 98 0.7× 7 458
Yong Bao China 16 195 0.9× 316 1.7× 318 1.8× 178 1.1× 74 0.5× 60 780
Franziska Hessel Germany 15 302 1.4× 299 1.7× 322 1.9× 53 0.3× 224 1.5× 22 716
Shuichi Kanamori Japan 15 92 0.4× 178 1.0× 322 1.9× 95 0.6× 184 1.2× 27 663
Yasunori Ariyoshi Japan 12 63 0.3× 227 1.3× 128 0.7× 50 0.3× 219 1.5× 31 668

Countries citing papers authored by Jens Overgaard

Since Specialization
Citations

This map shows the geographic impact of Jens Overgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Overgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Overgaard more than expected).

Fields of papers citing papers by Jens Overgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Overgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Overgaard. The network helps show where Jens Overgaard may publish in the future.

Co-authorship network of co-authors of Jens Overgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Overgaard. A scholar is included among the top collaborators of Jens Overgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Overgaard. Jens Overgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Alsner, Jan, et al.. (2001). TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiotherapy and Oncology. 59(2). 179–185. 74 indexed citations
2.
Alsner, Jan, et al.. (2001). Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology*Biology*Physics. 49(2). 519–525. 16 indexed citations
3.
Nordsmark, Marianne & Jens Overgaard. (2000). A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiotherapy and Oncology. 57(1). 39–43. 230 indexed citations
4.
Hansen, Olfred, Jens Overgaard, Marie Overgaard, et al.. (1997). Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiotherapy and Oncology. 43(1). 47–51. 121 indexed citations
5.
Horsman, Michael R., Marianne Nordsmark, Azza A. Khalil, et al.. (1994). Reducing Acute and Chronic Hypoxia in Tumours by Combining Nicotinamide with Carbogen Breathing. Acta Oncologica. 33(4). 371–376. 54 indexed citations
6.
7.
Bentzen, Søren M., Finn Lundbeck, Lise L. Christensen, & Jens Overgaard. (1992). Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder. Radiotherapy and Oncology. 25(4). 301–307. 18 indexed citations
8.
Grau, Cai & Jens Overgaard. (1991). Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo. International Journal of Radiation Oncology*Biology*Physics. 20(2). 265–269. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026